您的位置: 首页 > 农业专利 > 详情页

AN ORAL PHARMACEUTICAL FORMULATION COMPRISING SUSTAINED-RELEASE GRANULES CONTAINING TAMSULOSIN HYDROCHLORIDE
专利权人:
HANMI PHARM. CO.; LTD.
发明人:
Hyung Seo KIM,Young Keun CHOI,Jung Hyun CHO,Jin Cheul KIM,Yong Il KIM,Jae Hyun PARK,Jong Soo WOO
申请号:
US15551194
公开号:
US20180235913A1
申请日:
2016.02.16
申请国别(地区):
US
年份:
2018
代理人:
摘要:
An oral pharmaceutical formulation containing sustained-release granules including tamsulosin hydrochloride and a method of preparing the oral pharmaceutical formulation are provided. In the oral pharmaceutical formulation, the sustained-release granules includes about 10 parts to about 300 parts by weight of polyvinyl acetate, about 5 parts to about 250 parts by weight of hydroxypropyl methylcellulose, and about 1 part to about 450 parts by weight of a diluting agent with respect to 1 part by weight of tamsulosin hydrochloride, and a weight ratio of the sustained-release granules with respect to 1 part by weight of tamsulosin hydrochloride is about 360 to 495 parts by weight.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充